FindTrial
Sign In

Comparison of combined ultrasound guided PECS II block and combined ultrasound guided TPVB under general anesthesia for VATS mediastinal tumor resection vira anterolateral chest wall: a prospective, randomized, controlled clinical study.:

Comparison of combined ultrasound guided PECS II block and combined ultrasound guided TPVB under general anesthesia for VATS mediastinal tumor resection vira anterolateral chest wall: a prospective, randomized, controlled clinical study.:

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066632
Enrollment
Unknown
Registered
2022-12-12
Start date
2022-12-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mediastinal Tumor

Interventions

experimental group:modified PECS II
control group:TPVB

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients undergoing VATS mediastinal tumor resection via anterolateral chest wall approach. 2.Patients aged from 18 to 65 years' old. 3.ASA I-II

Exclusion criteria

Exclusion criteria: 1.Operations expected to last more than 4 hours 2.Patients with comorbidities such as neuropsychiatric disease and cannot cooperate with the researchers. 3.Patients with contraindications to regional blocks and allergic to local anesthetics.

Design outcomes

Primary

MeasureTime frame
perioperative opioid consumption;—

Secondary

MeasureTime frame
complications associated with regional nerve blocks;VAS pain score;—

Countries

China

Contacts

Public ContactJingxiang Wu

Shanghai Chest Hospital

wjx1132@163.com18930857186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026